A philanthropist, she became her late husband’s defender during the opioid crisis tied to the Sackler family name.

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

After Purdue Pharma agreed to a $7.4 billion settlement, the Sackler family, the company's founders, could see a hit to their net worth.

CHARLESTON — West Virginia could receive up to $53 million over the next nine years from a proposed settlement between the Sackler family — the owners of opioid manufacturer Purdue Pharma ...

A multi-billion dollar opioid epidemic settlement is being reached by Purdue Pharma, as well as its owners, the Sackler family, with attorneys general across the nation, Alabama Attorney General ...

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

Members of the Sackler family are expected to contribute between $6 billion and $7 billion to the settlement.

Purdue Pharma's $7.4 billion settlement marks a significant milestone in the opioid crisis, as all U.S. states agree to resolve litigation.

Georgia will receive $126 million for opioid addiction treatment and prevention as part of a $7.4 billion settlement with Purdue Pharma and the Sackler family.